U.S. stock futures slipped on Friday as a key central bank tightened policy and as key options contracts expire. Dow Jones Industrial Average futures fell 75 points, or 0.1%, to 46441. S&P 500 futures dropped 9 points,

Contracts on the S&P 500 rose 0.9% on Thursday, shaking off a choppy few hours after the Fed’s quarter-point reduction on Wednesday. Nasdaq 100 futures gained more than 1%. US government bonds recovered, with the 10-year yield slipping four basis points to 4.05%. The dollar held on to its post-Fed advance.

Stocks looked set to rise on Wednesday, as investors waited for the first of two key inflation reports that could help determine how many times the Federal Reserve will cut interest rates in 2025. Futures tracking the Dow Jones Industrial Average slipped 35 points,

The S&P 500 ended higher on Tuesday, lifted by Nvidia and Eli Lilly, while U.S. President Donald Trump's decision to fire a central bank governor deepened concerns about the Federal Reserve's independence.

The outlook for the S&P 500's dividends in the current and remaining quarters of 2025 has changed in the month since we presented our previous snapshot of their future.

With U.S. stock markets set to open in two hours, Bio-Rad Laboratories Inc. Cl B (BIO.B) was up 15.4% in pre-market trading, and Klaviyo Inc. (KVYO) was up 5.2%.

U.S. stock futures rose on Monday, building on gains last week ahead of a crucial Federal Reserve interest-rate decision while Nvidia lost ground on news of an adverse Chinese ruling. Dow Jones Industrial Average futures rose 75 points,